Half-year report · Q2
9273.TEDINET S100V85J
Period2024-07-01 → 2024-12-31
Filed2025-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥22.1bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.4bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥3.1bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥2.4bn | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥3.1bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.4bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥3.1bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.4bn | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.9bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.0bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥1.6bn | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥33.6bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥32.0bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥29.6bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.0bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥7.0bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥26.6bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥25.1bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥22.0bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.5bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.0bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.8bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.2bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.0bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.8bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.7bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.5bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥644m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥738m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥795m | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥639m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥48.66 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.14 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.46 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 79.1% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.3% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥604m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥604m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | ¥81m |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥8.0bn |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥7.4bn |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥604m |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥1.6bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥4.9bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥4.9bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| —segment total | revenue | 2024-07-01 → 2024-12-31 | ¥12.9bn |
| —segment total | revenue external | 2024-07-01 → 2024-12-31 | ¥12.3bn |
| —segment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥604m |
| —segment total | segment profit | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥871m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥871m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥38m |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥7.9bn |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥7.0bn |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥871m |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥1.4bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥4.4bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥4.4bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥1.0bn |
| —segment total | revenue | 2023-07-01 → 2023-12-31 | ¥12.3bn |
| —segment total | revenue external | 2023-07-01 → 2023-12-31 | ¥11.4bn |
| —segment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥871m |
| —segment total | segment profit | 2023-07-01 → 2023-12-31 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 494
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ca | Prior1YearInstant | 149505000 | JPY |
| Other ca | CurrentQuarterInstant | 179758000 | JPY |
| Current assets | Prior1YearInstant | 24775196000 | JPY |
| Current assets | CurrentQuarterInstant | 25081604000 | JPY |
| Buildings and structures | Prior1YearInstant | 5655516000 | JPY |
| Buildings and structures | CurrentQuarterInstant | 5648601000 | JPY |
| Accumulated depreciation buildings and structures | Prior1YearInstant | -2548576000 | JPY |
| Accumulated depreciation buildings and structures | CurrentQuarterInstant | -2648382000 | JPY |
| Buildings and structures net | Prior1YearInstant | 3106939000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 3000218000 | JPY |
| Machinery equipment and vehicles | Prior1YearInstant | 3844307000 | JPY |
| Machinery equipment and vehicles | CurrentQuarterInstant | 3850315000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | Prior1YearInstant | -2662715000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | CurrentQuarterInstant | -2829489000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 1181592000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 1020825000 | JPY |
| Tools furniture and fixtures | Prior1YearInstant | 1474651000 | JPY |
| Tools furniture and fixtures | CurrentQuarterInstant | 1494084000 | JPY |
| Accumulated depreciation tools furniture and fixtures | Prior1YearInstant | -1167010000 | JPY |
| Accumulated depreciation tools furniture and fixtures | CurrentQuarterInstant | -1192024000 | JPY |
| Tools furniture and fixtures net | Prior1YearInstant | 307641000 | JPY |
| Tools furniture and fixtures net | CurrentQuarterInstant | 302060000 | JPY |
| Land | Prior1YearInstant | 1761774000 | JPY |
| Land | CurrentQuarterInstant | 1821889000 | JPY |
| Construction in progress | Prior1YearInstant | 477884000 | JPY |
| Construction in progress | CurrentQuarterInstant | 2002870000 | JPY |
| Property plant and equipment | Prior1YearInstant | 6835831000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 8147864000 | JPY |
| Other ia | Prior1YearInstant | 11951000 | JPY |
| Other ia | CurrentQuarterInstant | 7931000 | JPY |
| Intangible assets | Prior1YearInstant | 11951000 | JPY |
| Intangible assets | CurrentQuarterInstant | 7931000 | JPY |
| Investment securities | Prior1YearInstant | 101074000 | JPY |
| Investment securities | CurrentQuarterInstant | 102890000 | JPY |
| Deferred tax assets | Prior1YearInstant | 244189000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 208576000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 23168000 | JPY |
| Net defined benefit asset | CurrentQuarterInstant | 15193000 | JPY |
| Other ioa | Prior1YearInstant | 12603000 | JPY |
| Other ioa | CurrentQuarterInstant | 11868000 | JPY |
| Investments and other assets | Prior1YearInstant | 381036000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 338529000 | JPY |
| Noncurrent assets | Prior1YearInstant | 7228819000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 8494324000 | JPY |
| Assets | Prior1YearInstant | 32004016000 | JPY |
| Assets | CurrentQuarterInstant | 33575928000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 1486785000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 1630870000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 718626000 | JPY |
| Electronically recorded obligations operating cl | CurrentQuarterInstant | 656039000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |